KENILWORTH, N.J., Sept. 19 /PRNewswire-FirstCall/ -- The Board of Directors of Schering-Plough Corporation today declared a quarterly dividend of 6.5 cents per common share. Payment will be made on Nov. 27, 2007, to shareholders of record at the close of business on Nov. 2, 2007. As of Sept. 14, 2007, there were 1,619,394,935 common shares outstanding.
The Board of Directors today also declared a quarterly dividend of $3.75 per share on the 2007 Mandatory Convertible Preferred Stock. Payment will be made on Nov. 15, 2007, to holders of record at the close of business on Nov. 1, 2007. As of August 15, 2007, there were 10,000,000 shares of 2007 Mandatory Convertible Preferred Stock outstanding.
Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough’s vision is to earn the trust of the physicians, patients and customers served by its approximately 33,500 people around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.
Schering-Plough Corporation
CONTACT: Media, Fred Malley, +1-908-298-7428; or Investors, Alex Kelly orRobyn Brown, +1-908-298-7436
Web site: http://www.schering-plough.com//
Company News On-Call: http://www.prnewswire.com/comp/777050.html/
